Sasol Form 20-F for the year ended 30 June 2021 - Book - Page 67
(10)
Aromatics: Further processing of Secunda value chain products in Sasolburg and the US: Phenol, cresylics and derivatives. Total global
integrated Aromatics capacity is 100kt.
(11)
Predominantly Ammonia.
has revised its previously reported results for 2019,
2020 and related disclosures. Readers are referred to
“Item 18—Financial Statements—Statement of
compliance” for further information on these revisions.
ITEM 4A. UNRESOLVED STAFF COMMENTS
There are no unresolved written comments
from the SEC staff regarding our periodic reports under
the Securities Exchange Act of 1934 received not less
than 180 days before 30 June 2021, that are considered
material.
Certain information contained in the
discussion and analysis set forth below and elsewhere
in this annual report includes forward-looking
statements that involve risks and uncertainties. See
“Forward-Looking Statements” and see “Item 3.D—
Risk factors” for a discussion of significant factors that
could cause actual results to differ materially from the
results described in or implied by the forward-looking
statements contained in this annual report.
ITEM 5. OPERATING AND FINANCIAL
REVIEW AND PROSPECTS
This section should be read in conjunction
with our consolidated financial statements included in
“Item 18—Financial Statements” as at 30 June 2021
and 2020, and for the years ended 30 June 2021, 2020
and 2019, including the accompanying notes, that are
included in this annual report on Form 20-F. The
following discussion of operating results and the
financial review and prospects as well as our
consolidated financial statements have been prepared in
accordance with IFRS as issued by the IASB.
5.A Operating results
Results of operations
Revised
2020
(Rand
in millions)
201 910
190 367
2021
Turnover . . . . . . . . .
Operating costs and
expenses . . . . . . . .
Remeasurement items .
Equity accounted
profits/(losses), net of
tax . . . . . . . . . . . .
Earnings/(loss) before
interest and tax . . .
Net finance costs . . . . .
Earnings/(loss) before
tax . . . . . . . . . . . .
Taxation . . . . . . . . . .
Earnings/(loss) . . . . . .
For information regarding our financial
overview and external factors impacting on our
business, refer to the “Integrated Report—Chief
Financial Officer’s performance overview” as
contained in Exhibit 99.3.
The discussion on the 2019 financial results
has not been included as this can be found under Item 5
of our Form 20-F for the year ended 30 June 2020,
except for the segmental results analysis and certain
comparative results which has been revised for the
correction of prior period errors. For more information,
please see “Item 18—Financial Statements—Note 1
Statement of compliance”
(162 887)
(23 218)
814
(189 968)
(111 978)
Change
2021/2020
(%)
6
( 14)
( 79)
Revised
Change
2019
2020/2019
(Rand
in millions)
(%)
203 576
(6)
(176 154)
(20 062)
8
458
(347)
( 335)
1 074
(132)
16 619
(5 902)
(111 926)
(6 381)
( 115)
( 7)
8 434
(466)
(1,427)
1,269
10 717
(185)
10 532
(118 307)
26 390
(91 917)
( 109)
( 101)
( 111)
7 968
(2 803)
5 165
(1,585)
(1,041)
(1,880)
Financial review 2021
During 2021, the group changed its reportable
operating segments. The group has provided its
historical segment information to be consistent with the
new reportable segment structure. The change in
reportable segments had no effect on the group’s
financial position, results of operations or cash flows
for the periods presented. Readers are referred to “Item
18—Financial Statements—Segment information” for
further information on our segments.
During 2021, the group also identified prior
period errors relating to its impairment calculations and
66
For information regarding our financial
condition, and an overview of our results
refer “Integrated Report—Performance
Overview—Chief Financial Officer’s
review” as contained in Exhibit 99.3.
For information on changes in our
financial condition, and overall financial
performance refer “Integrated Report—
Performance Overview—Chief Financial
Officer’s review”as contained in
Exhibit 99.3.